The notification amends the import policy for specific chemical and pharmaceutical items under Chapter 29 of ITC. A new Policy Condition No. 08 has been introduced, restricting imports of diluted Potassium Clavulanate, Potassium Clavulanate (KGA), and specified intermediates used in the manufacture of Clavulanic Acid or Potassium Clavulanate when imported below prescribed CIF value thresholds, up to 30th November 2026. However, exemptions are provided for Advance Authorisation holders, Export Oriented Units, and SEZ units, subject to the condition that the imported goods are not diverted to the Domestic Tariff Area.